What Pharma Can Learn From the Railroads and IBM

Pharmaceutical companies are in trouble with ongoing patent cliffs with a clear choice facing them. They can follow the path of the railroad industry which is the path most are on right now. Alternatively, they can follow the path IBM took when its future was similarly bleak. IBM demonstrated how it's possible for a large company to shift from a product-centric culture to a customer and service centered company. It's clear that pharma companies will succeed or fail based not on how many drugs they sell, but on how well their offerings improve health outcomes.

Source: http://feedproxy.google.com/~r/Techcrunch/~3/6YD1yoNJqmw/

eat to live eat to live ron paul money bomb ron paul money bomb bon vivant zynga ipo zynga ipo